Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6912 | 1352 | 21.3 | 80% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
126 | 23061 | TRANSPLANTATION//TRANSPLANTATION PROCEEDINGS//MYCOPHENOLIC ACID |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FK 506 | Author keyword | 6 | 16% | 3% | 37 |
2 | FUJISAWA AMER | Address | 6 | 58% | 1% | 7 |
3 | FUJISAWA AMER INC | Address | 4 | 75% | 0% | 3 |
4 | RAT LIVER ALLOTRANSPLANTATION | Author keyword | 2 | 67% | 0% | 2 |
5 | SURG TRANSPLANTAT C2122 | Address | 2 | 43% | 0% | 3 |
6 | EXPLORAT FONT RENALES | Address | 1 | 100% | 0% | 2 |
7 | EXTENDED RELEASE TACROLIMUS | Author keyword | 1 | 50% | 0% | 2 |
8 | IMMUNOL DIS AREA | Address | 1 | 50% | 0% | 2 |
9 | PHARMA TECHNOL S | Address | 1 | 100% | 0% | 2 |
10 | TACROLIMUS NEPHROTOXICITY | Author keyword | 1 | 40% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FK 506 | 84 | 20% | 28% | 375 |
2 | FK506 | 53 | 14% | 25% | 338 |
3 | HETEROTOPIC CARDIAC ALLOTRANSPLANTATION | 29 | 77% | 1% | 20 |
4 | RECEIVING FK 506 | 15 | 68% | 1% | 13 |
5 | RESISTANT REJECTION | 11 | 41% | 2% | 21 |
6 | FK 506 RESCUE THERAPY | 11 | 67% | 1% | 10 |
7 | DRUG FK 506 | 9 | 83% | 0% | 5 |
8 | FAILING CYCLOSPORINE IMMUNOSUPPRESSION | 9 | 83% | 0% | 5 |
9 | RESCUE IMMUNOSUPPRESSION | 9 | 67% | 1% | 8 |
10 | IMMUNOSUPPRESSIVE AGENT | 8 | 17% | 3% | 44 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Tacrolimus - A further update of its use in the management of organ transplantation | 2003 | 213 | 186 | 34% |
TACROLIMUS - A REVIEW OF ITS PHARMACOLOGY, AND THERAPEUTIC POTENTIAL IN HEPATIC AND RENAL-TRANSPLANTATION | 1993 | 251 | 283 | 56% |
Tacrolimus - A further update of its pharmacology and therapeutic use in the management of organ transplantation | 2000 | 139 | 275 | 44% |
Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials | 2010 | 33 | 33 | 48% |
The role of tacrolimus in adult kidney transplantation: a review | 1998 | 42 | 31 | 74% |
Tacrolimus in transplant rejection | 2013 | 10 | 68 | 44% |
FK506 (TACROLIMUS), A NOVEL IMMUNOSUPPRESSANT IN ORGAN-TRANSPLANTATION - CLINICAL, BIOMEDICAL, AND ANALYTICAL ASPECTS | 1993 | 88 | 95 | 61% |
Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients | 2005 | 38 | 78 | 54% |
Tacrolimus - An update of its pharmacology and clinical efficacy in the management of organ transplantation | 1997 | 190 | 160 | 37% |
Overview of tacrolimus-based immunosuppression after heart or lung transplantation | 2005 | 42 | 51 | 49% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FUJISAWA AMER | 6 | 58% | 0.5% | 7 |
2 | FUJISAWA AMER INC | 4 | 75% | 0.2% | 3 |
3 | SURG TRANSPLANTAT C2122 | 2 | 43% | 0.2% | 3 |
4 | EXPLORAT FONT RENALES | 1 | 100% | 0.1% | 2 |
5 | IMMUNOL DIS AREA | 1 | 50% | 0.1% | 2 |
6 | PHARMA TECHNOL S | 1 | 100% | 0.1% | 2 |
7 | UROL SURG TRANSPLANTAT | 1 | 40% | 0.1% | 2 |
8 | SECT RENAL TRANSPLANTAT RENOVASC SURG | 1 | 27% | 0.2% | 3 |
9 | ABLAC IMPLANTE ORGANOS | 1 | 50% | 0.1% | 1 |
10 | CARDIOL 1A | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000240241 | CYP3A5//TACROLIMUS//CYTOCHROME P450 3A5 |
2 | 0.0000194289 | POST TRANSPLANT DIABETES MELLITUS//NODAT//NEW ONSET DIABETES AFTER TRANSPLANTATION |
3 | 0.0000165511 | RHEUMATOLOTA KU//MDR I//DANINI HOSP |
4 | 0.0000118351 | SIMULTANEOUS LIVER KIDNEY TRANSPLANTATION//DUAL ORGAN TRANSPLANTATION//COMBINED TRANSPLANTATION |
5 | 0.0000108626 | STEROID WITHDRAWAL//CORTICOSTEROID WITHDRAWAL//EARLY STEROID WITHDRAWAL |
6 | 0.0000102240 | POSTTRANSPLANT HYPERLIPIDEMIA//ABT LEBENSMITTELSICHERHEIT 1//APOLIPOPROTEIN DISTRIBUTION |
7 | 0.0000098378 | DEOXYSPERGUALIN//15 DEOXYSPERGUALIN//AXE IMMUNOL |
8 | 0.0000091727 | PRINCESS ELISABETH CHILDRENS HOSP//ASTHMA ALLERG DIS IMMUNE DISORDERS//EOSINOPHILIC GASTROENTEROCOLITIS |
9 | 0.0000087824 | SIROLIMUS//EVEROLIMUS//PROLIFERATION SIGNAL INHIBITORS |
10 | 0.0000084808 | MYCOPHENOLIC ACID//MYCOPHENOLIC ACID GLUCURONIDE//MYCOPHENOLATE MOFETIL |